Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Harrow Inc (HROW)

Harrow Inc (HROW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,732,220
  • Shares Outstanding, K 37,037
  • Annual Sales, $ 199,610 K
  • Annual Income, $ -17,480 K
  • EBIT $ 28 M
  • EBITDA $ 47 M
  • 60-Month Beta 0.07
  • Price/Sales 8.26
  • Price/Cash Flow 325.58
  • Price/Book 35.30

Options Overview Details

View History
  • Implied Volatility 78.98% (+9.06%)
  • Historical Volatility 64.37%
  • IV Percentile 50%
  • IV Rank 40.18%
  • IV High 122.86% on 03/11/25
  • IV Low 49.50% on 08/29/25
  • Expected Move (DTE 14) 8.63 (18.86%)
  • Put/Call Vol Ratio 1.15
  • Today's Volume 573
  • Volume Avg (30-Day) 1,329
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 37,250
  • Open Int (30-Day) 42,846
  • Expected Range 37.12 to 54.38

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.45
  • Number of Estimates 3
  • High Estimate 0.55
  • Low Estimate 0.40
  • Prior Year 0.25
  • Growth Rate Est. (year over year) +80.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.55 +40.55%
on 11/11/25
47.90 -4.49%
on 12/05/25
+10.33 (+29.16%)
since 11/05/25
3-Month
32.55 +40.55%
on 11/11/25
50.72 -9.80%
on 09/26/25
+8.76 (+23.68%)
since 09/05/25
52-Week
20.85 +119.42%
on 04/09/25
50.72 -9.80%
on 09/26/25
+8.33 (+22.26%)
since 12/05/24

Most Recent Stories

More News
Harrow to Present at Two Investor Conferences in December

NASHVILLE, Tenn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will participate...

HROW : 45.75 (-2.18%)
Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the acquisition...

HROW : 45.75 (-2.18%)
Harrow: Q3 Earnings Snapshot

Harrow: Q3 Earnings Snapshot

HROW : 45.75 (-2.18%)
Harrow Announces Third Quarter 2025 Financial Results

Third-Quarter 2025 and Recent Selected Highlights:  Total revenues of $71.6 million, a 45% increase over $49.3 million recorded in the prior-year period GAAP net income of $1.0 million Adjusted...

HROW : 45.75 (-2.18%)
Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025

NASHVILLE, Tenn., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its financial...

HROW : 45.75 (-2.18%)
Craig-Hallum Sticks to Their Buy Rating for Harrow Health (HROW)

In a report released today, Chase Knickerbocker from Craig-Hallum reiterated a Buy rating on Harrow Health, with a price target of $64.00. The company’s shares closed last Friday at $37.48.Elevate Your...

HROW : 45.75 (-2.18%)
Craig-Hallum Sticks to Their Buy Rating for Harrow Health (HROW)

In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Harrow Health. The company’s shares closed last Friday at $45.43.Elevate Your Investing Strategy: Take advantage...

HROW : 45.75 (-2.18%)
Lake Street Sticks to Their Buy Rating for Harrow Health (HROW)

In a report released today, Brooks O’Neil from Lake Street maintained a Buy rating on Harrow Health, with a price target of $70.00. The company’s shares closed last Friday at $45.43.Elevate Your Investing...

HROW : 45.75 (-2.18%)
Harrow Health Announces New Leadership at ImprimisRx

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Harrow Health...

HROW : 45.75 (-2.18%)
ImprimisRx Announces Leadership Changes

Frank Mullery Appointed Chief Executive Officer of ImprimisRx Bridseida Cruz Appointed Head of Quality of ImprimisRx NASHVILLE, Tenn., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW),...

HROW : 45.75 (-2.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Harrow Inc. is an eyecare pharmaceutical company. It engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products principally for the U.S. market. Harrow Inc., formerly known as Harrow Health Inc., is based in NASHVILLE, Tenn.

See More

Key Turning Points

3rd Resistance Point 49.56
2nd Resistance Point 48.73
1st Resistance Point 47.24
Last Price 45.75
1st Support Level 44.92
2nd Support Level 44.09
3rd Support Level 42.60

See More

52-Week High 50.72
Last Price 45.75
Fibonacci 61.8% 39.31
Fibonacci 50% 35.78
Fibonacci 38.2% 32.26
52-Week Low 20.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar